• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Effect of baseline serum albumin concentration on outcome of resuscitation with albumin or saline in patients in intensive care units: analysis of data from the saline versus albumin fluid evaluation (SAFE) study.基线血清白蛋白浓度对重症监护病房患者使用白蛋白或生理盐水进行复苏结局的影响:盐水与白蛋白液体评估(SAFE)研究数据分析
BMJ. 2006 Nov 18;333(7577):1044. doi: 10.1136/bmj.38985.398704.7C. Epub 2006 Oct 13.
2
Commentary: Saline versus Albumin Fluid Evaluation (SAFE) Investigators (2006). Effect of baseline serum albumin concentration on outcome of resuscitation with albumin or saline in patients in intensive care units: analysis of data from the saline versus albumin fluid evaluation (SAFE) study.评论:生理盐水与白蛋白液体评估(SAFE)研究组(2006年)。基线血清白蛋白浓度对重症监护病房患者使用白蛋白或生理盐水复苏结局的影响:生理盐水与白蛋白液体评估(SAFE)研究数据分析。
Nurs Crit Care. 2007 May-Jun;12(3):168-9. doi: 10.1111/j.1478-5153.2007.00221.x.
3
The effects of saline or albumin resuscitation on acid-base status and serum electrolytes.生理盐水或白蛋白复苏对酸碱平衡状态和血清电解质的影响。
Crit Care Med. 2006 Dec;34(12):2891-7. doi: 10.1097/01.CCM.0000242159.32764.86.
4
Effects of saline or albumin resuscitation on standard coagulation tests.生理盐水或白蛋白复苏对常规凝血检测的影响。
Crit Care Resusc. 2009 Dec;11(4):250-6.
5
Effects of fluid resuscitation with synthetic colloids or crystalloids alone on shock reversal, fluid balance, and patient outcomes in patients with severe sepsis: a prospective sequential analysis.单独使用合成胶体或晶体液复苏对严重脓毒症休克逆转、液体平衡和患者结局的影响:一项前瞻性序贯分析。
Crit Care Med. 2012 Sep;40(9):2543-51. doi: 10.1097/CCM.0b013e318258fee7.
6
Statistical analysis plan for the Crystalloid Versus Hydroxyethyl Starch Trial (CHEST).晶体液与羟乙基淀粉试验(CHEST)的统计分析计划。
Crit Care Resusc. 2012 Mar;14(1):44-52.
7
A comparison of albumin and saline for fluid resuscitation in the intensive care unit.重症监护病房中白蛋白与生理盐水用于液体复苏的比较。
N Engl J Med. 2004 May 27;350(22):2247-56. doi: 10.1056/NEJMoa040232.
8
The PRECISE RCT: evolution of an early septic shock fluid resuscitation trial.PRECISE RCT:一项早期脓毒性休克液体复苏试验的演变。
Transfus Med Rev. 2012 Oct;26(4):333-41. doi: 10.1016/j.tmrv.2011.11.003. Epub 2012 Jan 4.
9
The Plasma-Lyte 148 v Saline (PLUS) study protocol: a multicentre, randomised controlled trial of the effect of intensive care fluid therapy on mortality.平衡液148对比生理盐水(PLUS)研究方案:一项关于重症监护液体疗法对死亡率影响的多中心随机对照试验。
Crit Care Resusc. 2017 Sep;19(3):239-246.
10
Low-volume resuscitation for severe intraoperative hemorrhage: a step in the right direction.严重术中出血的小容量复苏:朝着正确方向迈出的一步。
Am Surg. 2012 Sep;78(9):936-41.

引用本文的文献

1
Risk factors of linezolid-associated hyponatremia from a retrospective case-control study: decreased serum albumin as a selective predictor in elder patients.一项回顾性病例对照研究中利奈唑胺相关性低钠血症的危险因素:血清白蛋白降低作为老年患者的选择性预测指标
Ann Med. 2025 Dec;57(1):2551822. doi: 10.1080/07853890.2025.2551822. Epub 2025 Aug 31.
2
Association between serum creatinine-to-albumin ratio and 28-day mortality in intensive care unit patients following cardiac surgery: analysis of mimic-iv data.心脏手术后重症监护病房患者血清肌酐与白蛋白比值与28天死亡率的关联:MIMIC-IV数据的分析
BMC Cardiovasc Disord. 2025 Feb 14;25(1):100. doi: 10.1186/s12872-025-04505-1.
3
Correction: Fluid accumulation syndrome in sepsis and septic shock: pathophysiology, relevance and treatment-a comprehensive review.更正:脓毒症和脓毒性休克中的液体蓄积综合征:病理生理学、相关性及治疗——一篇综述
Ann Intensive Care. 2025 Jan 31;15(1):21. doi: 10.1186/s13613-024-01403-1.
4
Early Mortality Stratification with Serum Albumin and the Sequential Organ Failure Assessment Score at Emergency Department Admission in Septic Shock Patients.脓毒性休克患者急诊科入院时血清白蛋白及序贯器官衰竭评估评分的早期死亡分层
Life (Basel). 2024 Oct 2;14(10):1257. doi: 10.3390/life14101257.
5
Whole Body Physiologically Based Pharmacokinetic Model to Explain A Patient With Drug-Drug Interaction Between Voriconazole and Flucloxacillin.用于解释伏立康唑与氟氯西林药物相互作用患者的全身生理药代动力学模型。
Eur J Drug Metab Pharmacokinet. 2024 Nov;49(6):689-699. doi: 10.1007/s13318-024-00916-1. Epub 2024 Sep 14.
6
Associations between serum albumin level trajectories and clinical outcomes in sepsis patients in ICU: insights from longitudinal group trajectory modeling.重症监护病房脓毒症患者血清白蛋白水平轨迹与临床结局之间的关联:纵向群组轨迹模型的见解
Front Nutr. 2024 Jul 19;11:1433544. doi: 10.3389/fnut.2024.1433544. eCollection 2024.
7
Understanding antimicrobial pharmacokinetics in critically ill patients to optimize antimicrobial therapy: A narrative review.了解重症患者的抗菌药物药代动力学以优化抗菌治疗:一篇叙述性综述。
J Intensive Med. 2024 Feb 29;4(3):287-298. doi: 10.1016/j.jointm.2023.12.007. eCollection 2024 Jul.
8
Fluid accumulation syndrome in sepsis and septic shock: pathophysiology, relevance and treatment-a comprehensive review.脓毒症和脓毒性休克中的液体蓄积综合征:病理生理学、相关性及治疗——一项全面综述
Ann Intensive Care. 2024 Jul 20;14(1):115. doi: 10.1186/s13613-024-01336-9.
9
Development of a Simple Scoring System for Predicting Discharge Safety from the Medical ICU to Low-Acuity Wards: The Role of the Sequential Organ Failure Assessment Score, Albumin, and Red Blood Cell Distribution Width.开发一种用于预测从医学重症监护病房转至低 acuity 病房出院安全性的简单评分系统:序贯器官衰竭评估评分、白蛋白和红细胞分布宽度的作用。 (注:这里“low - acuity”直译为“低敏锐度”,结合语境意译为“低 acuity”,你可根据实际情况调整表述)
J Pers Med. 2024 Jun 16;14(6):643. doi: 10.3390/jpm14060643.
10
Prognostic value of red blood cell distribution width to albumin ratio for predicting mortality in adult patients meeting sepsis-3 criteria in intensive care units.红细胞分布宽度与白蛋白比值对 ICU 符合 Sepsis-3 标准的成年患者死亡率的预测价值。
BMC Anesthesiol. 2024 Jun 14;24(1):208. doi: 10.1186/s12871-024-02585-8.

本文引用的文献

1
Human albumin solution for resuscitation and volume expansion in critically ill patients.用于危重症患者复苏和容量扩充的人血白蛋白溶液
Cochrane Database Syst Rev. 2004 Oct 18(4):CD001208. doi: 10.1002/14651858.CD001208.pub2.
2
Morbidity in hospitalized patients receiving human albumin: a meta-analysis of randomized, controlled trials.接受人血白蛋白治疗的住院患者的发病率:一项随机对照试验的荟萃分析。
Crit Care Med. 2004 Oct;32(10):2029-38. doi: 10.1097/01.ccm.0000142574.00425.e9.
3
Is albumin safe?白蛋白安全吗?
N Engl J Med. 2004 May 27;350(22):2294-6. doi: 10.1056/NEJMe048095.
4
A comparison of albumin and saline for fluid resuscitation in the intensive care unit.重症监护病房中白蛋白与生理盐水用于液体复苏的比较。
N Engl J Med. 2004 May 27;350(22):2247-56. doi: 10.1056/NEJMoa040232.
5
Albumin influences total plasma antioxidant capacity favorably in patients with acute lung injury.白蛋白对急性肺损伤患者的血浆总抗氧化能力有积极影响。
Crit Care Med. 2004 Mar;32(3):755-9. doi: 10.1097/01.ccm.0000114574.18641.5d.
6
Hypoalbuminemia in acute illness: is there a rationale for intervention? A meta-analysis of cohort studies and controlled trials.急性疾病中的低白蛋白血症:是否有干预的理论依据?队列研究和对照试验的荟萃分析。
Ann Surg. 2003 Mar;237(3):319-34. doi: 10.1097/01.SLA.0000055547.93484.87.
7
Albumin and furosemide therapy in hypoproteinemic patients with acute lung injury.白蛋白与呋塞米治疗急性肺损伤低蛋白血症患者
Crit Care Med. 2002 Oct;30(10):2175-82. doi: 10.1097/00003246-200210000-00001.
8
The role of albumin in critical illness.白蛋白在危重病中的作用。
Br J Anaesth. 2000 Oct;85(4):599-610. doi: 10.1093/bja/85.4.599.
9
Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on "sepsis-related problems" of the European Society of Intensive Care Medicine.使用序贯器官衰竭评估(SOFA)评分来评估重症监护病房中器官功能障碍/衰竭的发生率:一项多中心前瞻性研究的结果。欧洲重症监护医学学会“脓毒症相关问题”工作组
Crit Care Med. 1998 Nov;26(11):1793-800. doi: 10.1097/00003246-199811000-00016.
10
Human albumin administration in critically ill patients: systematic review of randomised controlled trials.危重症患者使用人白蛋白:随机对照试验的系统评价
BMJ. 1998 Jul 25;317(7153):235-40. doi: 10.1136/bmj.317.7153.235.

基线血清白蛋白浓度对重症监护病房患者使用白蛋白或生理盐水进行复苏结局的影响:盐水与白蛋白液体评估(SAFE)研究数据分析

Effect of baseline serum albumin concentration on outcome of resuscitation with albumin or saline in patients in intensive care units: analysis of data from the saline versus albumin fluid evaluation (SAFE) study.

作者信息

Finfer Simon, Bellomo Rinaldo, McEvoy Suzanne, Lo Sing Kai, Myburgh John, Neal Bruce, Norton Robyn

机构信息

Australian and New Zealand Intensive Care Society Clinical Trials Group, Carlton, Vic 3053, Australia.

出版信息

BMJ. 2006 Nov 18;333(7577):1044. doi: 10.1136/bmj.38985.398704.7C. Epub 2006 Oct 13.

DOI:10.1136/bmj.38985.398704.7C
PMID:17040925
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1647335/
Abstract

OBJECTIVE

To determine whether outcomes of resuscitation with albumin or saline in the intensive care unit depend on patients' baseline serum albumin concentration.

DESIGN

Analysis of data from a double blind, randomised controlled trial.

SETTING

Intensive care units of 16 hospitals in Australia and New Zealand.

PARTICIPANTS

6045 participants in the saline versus albumin fluid evaluation (SAFE) study.

INTERVENTIONS

Fluid resuscitation with 4% albumin or saline in patients with a baseline serum albumin concentration of 25 g/l or less or more than 25 g/l.

MAIN OUTCOME MEASURES

Primary outcome was all cause mortality at 28 days. Secondary outcomes were length of stay in the intensive care unit, length of stay in hospital, duration of renal replacement therapy, and duration of mechanical ventilation.

MAIN RESULTS

The odds ratios for death for albumin compared with saline for patients with a baseline serum albumin concentration of 25 g/l or less and more than 25 g/l were 0.87 and 1.09, respectively (ratio of odds ratios 0.80, 95% confidence interval 0.63 to 1.02); P=0.08 for heterogeneity. No significant interaction was found between baseline serum albumin concentration as a continuous variable and the effect of albumin and saline on mortality. No consistent interaction was found between baseline serum albumin concentration and treatment effects on length of stay in the intensive care unit, length of hospital stay, duration of renal replacement therapy, or duration of mechanical ventilation.

CONCLUSION

The outcomes of resuscitation with albumin and saline are similar irrespective of patients' baseline serum albumin concentration.

TRIAL REGISTRATION

ISRCTN76588266.

摘要

目的

确定在重症监护病房使用白蛋白或生理盐水进行复苏的结果是否取决于患者的基线血清白蛋白浓度。

设计

对一项双盲随机对照试验的数据进行分析。

地点

澳大利亚和新西兰16家医院的重症监护病房。

参与者

盐水与白蛋白液体评估(SAFE)研究中的6045名参与者。

干预措施

对基线血清白蛋白浓度为25g/L及以下或高于25g/L的患者,分别用4%白蛋白或生理盐水进行液体复苏。

主要结局指标

主要结局为28天的全因死亡率。次要结局包括在重症监护病房的住院时间、住院总时长、肾脏替代治疗时间以及机械通气时间。

主要结果

基线血清白蛋白浓度为25g/L及以下和高于25g/L的患者,使用白蛋白与生理盐水相比的死亡比值比分别为0.87和1.09(比值比之比为0.80,95%置信区间为0.63至1.02);异质性检验P = 0.08。未发现基线血清白蛋白浓度作为连续变量与白蛋白和生理盐水对死亡率的影响之间存在显著交互作用。在基线血清白蛋白浓度与对重症监护病房住院时间、住院总时长、肾脏替代治疗时间或机械通气时间的治疗效果之间,未发现一致的交互作用。

结论

无论患者的基线血清白蛋白浓度如何,使用白蛋白和生理盐水进行复苏的结果相似。

试验注册号

ISRCTN76588266。